Featured
Inconsistent home BP readings often trace to device choice and technique, not your health. Here is how to pick a validated cuff and measure like a clinician.
Updated flu and COVID shots are expected this fall with insurer coverage despite a stalled federal advisory committee. Here is what to do right now.
Generic drug shortages are rising, leaving patients scrambling for staples like stimulants, antibiotics, and sterile injectables. Here is why it happens and what to do when your drug is gone.
Updated guidelines now recommend at-home HPV self-swab testing as an option for cervical cancer screening. Here is who qualifies, how it works, and what the results mean.
A 2026 Mayo analysis found hormone therapy use fell to 1.7 percent by 2023 despite stronger evidence. Here is the gap between the data and the prescription pad.
Iron deficiency can cause exhaustion, brain fog, and breathlessness long before anemia shows up. Here is why ferritin testing matters and how to fix it.
The FDA's over-the-counter hearing aid rule has been in effect since 2022, but many buyers still struggle. Here is how to choose, what to expect, and when you still need a clinician.
In 2026 HHS moved flu, COVID, HepA, HepB, meningococcal, and rotavirus off the universal recommendation list. Here is what changed, what stays covered, and what parents should do.
Shingrix has long been recommended from age 50, but more younger adults with risk factors are getting it. Here is who should consider it and why timing matters.
The FDA approved suzetrigine (Journavx) in January 2025 as the first new-class non-opioid pain pill in decades. Here is how it works, who it helps, and its limits.
Testosterone prescriptions are climbing as the 2023 TRAVERSE trial cleared major cardiac fears. Here is what the evidence shows, who benefits, and the real remaining risks.
Routine vitamin D supplementation for healthy adults lacks strong proof of benefit. Here is who actually needs testing and treatment, and who is wasting money.
Zurzuvae (zuranolone) is a 14-day pill for postpartum depression, a faster alternative to infusion therapy. Here is how it works, who it helps, and what to watch for.
A 2026 analysis says CGMs may complement standard tests for prediabetes detection. Here is who actually benefits from wearing one, what it shows, and what it cannot tell you.
FDA enforcement ended the routine compounding of semaglutide and tirzepatide in 2026. If your cheap telehealth GLP-1 just stopped refilling, here is a safe path to a legal alternative.
Enlicitide (Lipfendra), the first oral PCSK9 inhibitor, won FDA approval in July 2026 and cuts LDL by more than half. Here is who it helps and how it fits with statins.
FDA drug and supplement recalls surged in 2026 — from a TikTok collagen recall to a dabigatran impurity pull. Here is the step-by-step way to check whether your bottle is affected before you take it.
Tirzepatide and orforglipron labels warn that slowed digestion can blunt oral birth control. Here is the backup-window rule every woman on the pill and a GLP-1 needs to know.
